We are performing an LC ESI MS/MS protocol to quantify Gliclazide on plasma samples. We have noticed that the internal standard (Gliclazide D4) has a very high variation compared with gliclazide. The D4 shows high variation not only among runs but also injections on the same run.

We have also noticed that as the run is going there is an increment in the signal during the calibration curve and a lower signal during the sample run in the same plate with the same sample preparation.

The run looks good because the relation of areas with the internal and the analyte agree on the calibration curve and the QC, yet the difference with the signal on the samples makes us reject the run.

We need help solving this or otherwise a good explanation on this behavior to justify not doing the reanalysis.

Any literature will help a lot.

If you need information on the used system and conditions of the run I can supply them.

More Jose Herrera's questions See All
Similar questions and discussions